Dyne Therapeutics's total assets for Q3 2025 were $867.06M, an increase of 18.94% from the previous quarter. DYN total liabilities were $175.28M for the fiscal quarter, a 11.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.